In Vitro Investigation of the Cytotoxic Activity of Emodin 35 Derivative on Multiple Myeloma Cell Lines

BACKGROUND: Bortezomib is used for treating multiple myeloma (MM); however, it has considerable adverse effects. Emodin has been reported to exhibit inhibitory effects on MM cell lines. We investigated the efficacy of emodin 35 (E35), an emodin derivative, using U266 and MM1s cell lines in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing, Chen, Yingyu, Zheng, Zhihong, Chen, Yanxin, Chai, Yujuan, Wang, Wenfeng, Asakawa, Tetsuya, Hu, Jianda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850823/
https://www.ncbi.nlm.nih.gov/pubmed/33564319
http://dx.doi.org/10.1155/2021/6682787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850823/
https://www.ncbi.nlm.nih.gov/pubmed/33564319
http://dx.doi.org/10.1155/2021/6682787

Ejemplares similares